The global neurology clinical trials market is projected to experience substantial growth, with a predicted increase from US$ 5.7 billion in 2022 to US$ 10.5 billion by 2032, marking a noteworthy Compound Annual Growth Rate (CAGR) of 6.3%. This surge in market size is primarily attributed to several factors including the escalating prevalence of neurological …